Because pregnancy is not a standard diabetes use case
Nerve regeneration: Improved electrophysiological parameters motor nerve conduction velocity and compound muscle action potentials measurable at 68 weeks post-transection (Gjurasin et al., 2010)
Exenatide Overview : Exenatide, like semaglutide, is a GLP-1 receptor agonist used for diabetes management Pros : Effective for blood sugar control and potential weight loss Cons : Requires injections, and it may have side effects 5
Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2018 and June 30, 2024
All our contact information can be found from our website
Retatrutide is still investigational, so it should not be described as FDA-approved or as having an established safety profile for routine prescribing